Mankind Pharma Limited (BOM:543904)
2,524.85
-6.50 (-0.26%)
At close: Jul 10, 2026
Mankind Pharma Market Cap
Mankind Pharma has a market cap or net worth of 1.04 trillion as of July 13, 2026. Its market cap has increased by 7.91% in one year.
Market Cap
1.04T
Enterprise Value
1.08T
Revenue
142.78B
Ranking
n/a
PE Ratio
54.14
Stock Price
2,524.85
Market Cap Chart
Since May 9, 2023, Mankind Pharma's market cap has increased from 569.76B to 1.04T, an increase of 81.76%. That is a compound annual growth rate of 20.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 1.04T | 15.01% |
| Dec 31, 2025 | 906.73B | -23.70% |
| Dec 31, 2024 | 1.19T | 49.64% |
| Dec 29, 2023 | 794.17B | 39.39% |
| May 9, 2023 | 569.76B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Torrent Pharmaceuticals | 1.66T |
| Lupin | 1.14T |
| Dr. Reddy's Laboratories | 1.06T |
| Abbott India | 568.70B |
| GlaxoSmithKline Pharmaceuticals | 412.59B |
| J. B. Chemicals & Pharmaceuticals | 391.92B |
| Rubicon Research | 231.84B |
| Granules India | 218.35B |